204 related articles for article (PubMed ID: 31938020)
1. LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis.
Wu L; Zhu L; Li Y; Zheng Z; Lin X; Yang C
Cancer Cell Int; 2020; 20():12. PubMed ID: 31938020
[TBL] [Abstract][Full Text] [Related]
2. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.
Long J; Pi X
Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
[TBL] [Abstract][Full Text] [Related]
3. Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208/SOX4.
Yang Y; Jin L; He J; Wang R; Wang Y; Bai J; Chen Y; Luo Z
Mol Cell Biochem; 2023 Feb; 478(2):407-414. PubMed ID: 35838912
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway.
Li P; Gao Y; Li J; Zhou Y; Yuan J; Guan H; Yao P
J Cell Biochem; 2018 Sep; 119(9):7498-7505. PubMed ID: 29781534
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
8. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma.
Wei Q; Liu G; Huang Z; Huang Y; Huang L; Huang Z; Wu X; Wei H; Pu J
J Hepatocell Carcinoma; 2023; 10():1019-1035. PubMed ID: 37435155
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-MEG3 inhibits proliferation and metastasis by regulating miRNA-21 in gastric cancer.
Dan J; Wang J; Wang Y; Zhu M; Yang X; Peng Z; Jiang H; Chen L
Biomed Pharmacother; 2018 Mar; 99():931-938. PubMed ID: 29710493
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4.
Ning J; Zhang L; Guo H; Zhou S; Sun X; Bao W
Transl Cancer Res; 2020 Feb; 9(2):958-971. PubMed ID: 35117441
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma.
Fan FY; Deng R; Yi H; Sun HP; Zeng Y; He GC; Su Y
Int J Oncol; 2017 Jul; 51(1):316-326. PubMed ID: 28534937
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA CAR10 Contributes to Melanoma Progression By Suppressing miR-125b-5p to Induce RAB3D Expression.
Xie J; Zheng Y; Xu X; Sun C; Lv M
Onco Targets Ther; 2020; 13():6203-6211. PubMed ID: 32636644
[TBL] [Abstract][Full Text] [Related]
14. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC00847 accelerates melanoma progression by regulating miR-133a-3p/TGFBR1 axis.
Jiang L; Shi X; Liu Y; Chen H
Comb Chem High Throughput Screen; 2023 Aug; ():. PubMed ID: 37587809
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MEG3 inhibits self-renewal and invasion abilities of oral cancer stem cells by sponging miR-421.
Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Yu CC
J Formos Med Assoc; 2021 Apr; 120(4):1137-1142. PubMed ID: 33012637
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells.
Tao Y; Yue P; Miao Y; Gao S; Wang B; Leng SX; Meng X; Zhang H
J Gene Med; 2021 Feb; 23(2):e3291. PubMed ID: 33141998
[TBL] [Abstract][Full Text] [Related]
18. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
19. LncRNA POU3F3 promotes melanoma cell proliferation by downregulating lncRNA MEG3.
Liu Y; Zhuang Y; Fu X; Li C
Discov Oncol; 2021 Jul; 12(1):21. PubMed ID: 35201451
[TBL] [Abstract][Full Text] [Related]
20. The overexpression of lncRNA MEG3 inhibits cell viability and invasion and promotes apoptosis in ovarian cancer by sponging miR-205-5p.
Tao P; Yang B; Zhang H; Sun L; Wang Y; Zheng W
Int J Clin Exp Pathol; 2020; 13(5):869-879. PubMed ID: 32509057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
